Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Scientists ID drug dosage for fungal disease
Aspergillosis is a respiratory fungal disease commonly seen in African penguins under managed care.
Treatment previously caused adverse effects in penguins
 
Liverpool researchers have found the most effective drug dosage to help penguins fight off a common disease.

Aspergillosis is a respiratory fungal disease commonly seen in African penguins under managed care. The anti-fungal medication itraconazole, which was previously used to treat the disease, failed due to drug resistance.

Another anti-fungal called voriconazole has been used recently, but the dosing was based on other avian medications and penguins suffered adverse effects as a result.

Researchers from the University of Liverpool wanted to identify the most effective dose of the drug. Led by Dr Katharine Stott, the team analysed the concentration of voriconazole in plasma taken from African penguins, in order to determine the effectiveness of multiple single and daily oral doses.

This data was used to construct a mathematical model to simulate alternative dosing strategies to find one that replicated the drug exposure that is effective in humans, whilst avoiding toxicity.

The findings, which were published in BioOne, show that 5mg/kg of voriconazole once a day is a safe and effective dosing strategy for African penguins with invasive aspergillosis.

Become a member or log in to add this story to your CPD history

Applications open for MMI research grants

News Story 1
 RCVS' Mind Matters Initiative (MMI) has launched round two of its veterinary mental health research grants.

Researchers have until 11.59pm on Wednesday, 28 May 2025 to apply for a grant for research which reflects MMI's 2025 focus areas.

Only one Impact Grant was awarded last year, and so this year there are two Discovery Grants and one Impact Grants available. Each Discovery Grant is worth £5,000 and the Impact Grant is worth £15,000.

For more information or to apply, email researchgrants@rcvs.org.uk to contact the MMI team.

 

Click here for more...
News Shorts
BBC Radio 4 documentary addresses corporate fees

BBC Radio 4's File on 4 Investigates has released a documentary exploring how corporate-owned veterinary practices may be inflating bills to increase profit.

Released on 15 April, 'What's Happening To Your Vet Bills?' revealed the policies which many corporate groups have in place to increase their profits. This included targets and upgrades which veterinary teams are tasked with meeting on a regular basis.

It also features Anrich Vets, an independently-owned practice based in Wigan. Following the case of Staffordshire terrier Benjy, who is diagnosed with a tumour, the documentary shares how the team were able to offer contextualised care and advice to make the procedure as affordable as possible for his owners.

The documentary can be heard on demand on BBC iPlayer.